10:22 AM EST - MediPharm Labs Corp. : Has signed its first private label sales agreement for export to Europe, with ADREXpharma® GmbH, a leading licensed wholesale distributor of controlled drugs and medical cannabis which can serve all of the approximate 20,000 pharmacies across Germany. Through its private label solutions platform, MediPharm Labs will supply ADREXpharma with high quality, purity assured, cannabis concentrate derivative products, including THC and CBD oil, for sale and distribution under the ADREXpharma brand in Germany upon receipt of applicable regulatory approvals. MediPharm Labs Corp.
shares T.LABS are trading up $0.01 at $4.79.
